MedPath

Pilot study to reduce anticholinergic load

Conditions
Drug therapy safety
Registration Number
DRKS00012346
Lead Sponsor
Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Patient admitted to the Geriatric Rehabilitation of the Agaplesion Bethanien Hospital in Heidelberg; Age = 65 years;
Taking at least one strong anticholinergic drug on a regular basis (this condition does not affect the comparison group);
cognitive and physical stable to participate in the study

Exclusion Criteria

Mental or physical condition which does not allow the study participation; Particularly, patients with stroke, postoperative delirium, or dementia are excluded; Missing informed consent

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development and testing of different models for predicting anticholinergic load (time point of analysis: study end); Examination of the practicability of the decision aid for reducing anticholinergic load via feedback questionnaires of the participating physicians (time point of examination: during study).
Secondary Outcome Measures
NameTimeMethod
Characterization of patients with different anticholinergic loads by cognition tests as well as by the assessment of anticholinergic adverse drug reactions at admission and approximately 14 days later (time of examination: during study).
© Copyright 2025. All Rights Reserved by MedPath